273 related articles for article (PubMed ID: 32474122)
1. Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.
Liu J; Nie S; Wu Z; Jiang Y; Wan Y; Li S; Meng H; Zhou S; Cheng W
Genomics; 2020 Sep; 112(5):3117-3134. PubMed ID: 32474122
[TBL] [Abstract][Full Text] [Related]
2. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
[TBL] [Abstract][Full Text] [Related]
3. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
Front Immunol; 2021; 12():788431. PubMed ID: 34970268
[TBL] [Abstract][Full Text] [Related]
4. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer.
Wang G; Wang D; Sun M; Liu X; Yang Q
Int Immunopharmacol; 2020 Nov; 88():106931. PubMed ID: 32889237
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
Cheng P; Ma J; Zheng X; Zhou C; Chen X
Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
[TBL] [Abstract][Full Text] [Related]
7. PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma.
Tao Y; Liang B
Pathol Res Pract; 2020 Jun; 216(6):152943. PubMed ID: 32279917
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
Liu J; Xu W; Li S; Sun R; Cheng W
Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
[No Abstract] [Full Text] [Related]
11. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
Liu J; Chen X; Jiang Y; Cheng W
Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
[TBL] [Abstract][Full Text] [Related]
12. The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling.
Xu L; Fang Q; Miao Y; Xu M; Wang Y; Sun L; Jia X
Bioengineered; 2021 Dec; 12(1):3467-3484. PubMed ID: 34251980
[TBL] [Abstract][Full Text] [Related]
13. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
14. Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification.
Chen Y; You S; Li J; Zhang Y; Kokaraki G; Epstein E; Carlson J; Huang WK; Haglund F
Front Immunol; 2021; 12():788959. PubMed ID: 35069566
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract][Full Text] [Related]
16. ATM mutations as an independent prognostic factor and potential biomarker for immune checkpoint therapy in endometrial cancer.
Sun L; Wang RC; Zhang Q; Guo LL
Pathol Res Pract; 2020 Aug; 216(8):153032. PubMed ID: 32703496
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas.
Zhang S; Minaguchi T; Xu C; Qi N; Itagaki H; Shikama A; Tasaka N; Akiyama A; Sakurai M; Ochi H; Satoh T
BMC Cancer; 2020 Feb; 20(1):127. PubMed ID: 32066405
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.
Li BL; Wan XP
J Cell Mol Med; 2020 Jul; 24(14):7767-7777. PubMed ID: 32424934
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of two redox-related genes associated with prognosis and immune microenvironment in endometrial carcinoma.
He Y; Cao N; Tian Y; Wang X; Xiao Q; Tang X; Huang J; Zhu T; Hu C; Zhang Y; Deng J; Yu H; Duan P
Math Biosci Eng; 2023 Mar; 20(6):10339-10357. PubMed ID: 37322935
[TBL] [Abstract][Full Text] [Related]
20. Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer.
Zhang Y; Hu Y; Yu J; Xie X; Jiang F; Wu C
J Ovarian Res; 2023 Jul; 16(1):129. PubMed ID: 37393293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
